Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000377201 | SCV000334161 | uncertain significance | not provided | 2015-09-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002429215 | SCV002681445 | uncertain significance | Inborn genetic diseases | 2017-07-12 | criteria provided, single submitter | clinical testing | The p.L276F variant (also known as c.826C>T), located in coding exon 4 of the SLC35A2 gene, results from a C to T substitution at nucleotide position 826. The leucine at codon 276 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV002521886 | SCV003279765 | benign | SLC35A2-congenital disorder of glycosylation | 2024-07-03 | criteria provided, single submitter | clinical testing |